A genome-wide association study for colorectal cancer identifies a risk locus in 14q23.1.
СтатьяПоддержка NIH: внешняя программаПоддержка исследования: вне правительства СШАПоддержка службы здравоохранения СШАНазвание и аннотация: Перевод в очереди
Обработка статьи · этапы, ошибки и управление
Загрузка состояния…
Ошибки и ограничения
История · было → стало
Состояние обновляется каждые 5 секунд, пока блок открыт. Процент показывается только там, где известен объём работы. Пауза останавливает продолжение этапа; текущий запрос к источнику может завершиться.
Lemire Mathieu, Qu Conghui, Loo Lenora W M, Zaidi Syed H E, Wang Hansong, Berndt Sonja I, Bézieau Stéphane, Brenner Hermann, Campbell Peter T, Chan Andrew T, Chang-Claude Jenny, Du Mengmeng, Edlund Christopher K, Gallinger Steven, Haile Robert W, Harrison Tabitha A, Hoffmeister Michael, Hopper John L, Hou Lifang, Hsu Li, Jacobs Eric J, Jenkins Mark A, Jeon Jihyoun, Küry Sébastien, Li Li, Lindor Noralane M, Newcomb Polly A, Potter John D, Rennert Gad, Rudolph Anja, Schoen Robert E, Schumacher Fredrick R, Seminara Daniela, Severi Gianluca, Slattery Martha L, White Emily, Woods Michael O, Cotterchio Michelle, Marchand Loic Le, Casey Graham, Gruber Steven B, Peters Ulrike, Hudson Thomas J
Аннотация
Over 50 loci associated with colorectal cancer (CRC) have been uncovered by genome-wide association studies (GWAS). Identifying additional loci has the potential to help elucidate aspects of the underlying biological processes leading to better understanding of the pathogenesis of the disease. We re-evaluated a GWAS by excluding controls that have family history of CRC or personal history of colorectal polyps, as we hypothesized that their inclusion reduces power to detect associations. This is supported empirically and through simulations. Two-phase GWAS analysis was performed in a total of 16,517 cases and 14,487 controls. We identified rs17094983, a SNP associated with risk of CRC [p = 2.5 × 10(-10); odds ratio estimated by re-including all controls (OR) = 0.87, 95% confidence interval (CI) 0.83-0.91; minor allele frequency (MAF) = 13%]. Results were replicated in samples of African descent (1894 cases and 4703 controls; p = 0.01; OR = 0.86, 95% CI 0.77-0.97; MAF = 16 %). Gene expression data in 195 colon adenocarcinomas and 59 normal colon tissues from two different studies revealed that this locus has genotypes that are associated with RTN1 (Reticulon 1) expression (p = 0.001), a protein-coding gene involved in survival and proliferation of cancer cells which is highly expressed in normal colon tissues but has significantly reduced expression in tumor cells (p = 1.3 × 10(-8)).